---
layout: post
title: "RARE Stockholder Alert: Robbins LLP Reminds Investors of the Class Action Against Ultragenyx Pharmaceutical Inc."
date: 2026-02-06T07:00:00+00:00
source: PR Newswire Releases
source_url: https://www.prnewswire.com/news-releases/rare-stockholder-alert-robbins-llp-reminds-investors-of-the-class-action-against-ultragenyx-pharmaceutical-inc-302680894.html
significance: 7.00
---

<p>SAN DIEGO, Feb. 6, 2026 /PRNewswire/ -- Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) common stock between August 3, 2023 and December 26, 2025. Ultragenyx is a...</p>

**Source:** [PR Newswire Releases](https://www.prnewswire.com/news-releases/rare-stockholder-alert-robbins-llp-reminds-investors-of-the-class-action-against-ultragenyx-pharmaceutical-inc-302680894.html)

**Published:** 2026-02-06 07:00:00 +0000

**Significance Score:** 7.00

[View original](https://www.prnewswire.com/news-releases/rare-stockholder-alert-robbins-llp-reminds-investors-of-the-class-action-against-ultragenyx-pharmaceutical-inc-302680894.html)
